Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Endovia Health Sciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q4 2022
- Shares held
- 2.10M
- −176.6K (−7.8%) vs. Q4 2022
- Total value
- $3.45M
- +$1.26M (+57.4%) vs. Q4 2022
- New holders
- 3
- 5 more added
- Sold out
- 6
- 5 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,257,887 | $2.06M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 223,120 | $365.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 102,300 | $167.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 85,961 | $141.0K | 0.00% | −128,568−59.9% | Reduced |
| BlackRock Inc. | 75,206 | $123.3K | 0.00% | +12,797+20.5% | Added |
| State Street Corp | 70,000 | $114.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 62,308 | $102.2K | 0.00% | −17,265−21.7% | Reduced |
| Northern Trust Corp | 49,754 | $81.6K | 0.00% | +7,136+16.7% | Added |
| Parsons Capital Management Inc | 33,249 | $54.5K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 26,000 | $42.6K | 0.00% | +26,000 | New |
| Cambridge Investment Research Advisors, Inc. | 24,264 | $40.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 20,360 | $33.4K | 0.00% | +20,360 | New |
| Morgan Stanley | 14,200 | $23.3K | 0.00% | −2,652−15.7% | Reduced |
| Simplex Trading, LLC | 14,454 | $23.0K | 0.00% | +12,185+537.0% | Added |
| Tower Research Capital LLC (TRC) | 11,936 | $20.0K | 0.00% | +2,846+31.3% | Added |
| Bank of New York Mellon Corp | 11,709 | $19.2K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 10,000 | $16.4K | 0.00% | −630−5.9% | Reduced |
| UBS Group AG | 6,130 | $10.1K | 0.00% | −1,876−23.4% | Reduced |
| Royal Bank of Canada | 3,000 | $5.00K | 0.00% | +3,000 | New |
| Wells Fargo & Company | 200 | $328 | 0.00% | +4+2.0% | Added |
| FMR LLC | 5 | $8 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −41,495−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −28,255−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −15,533−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −10,360−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −37−100.0% | Sold out |